Abbott CFO uses 388 shares to cover tax at $110.36
Abbott’s EVP and CFO used 388 shares to cover option exercise or tax obligations and now reports direct and indirect ownership totaling several share blocks.
Rhea-AI Filing Summary
ABBOTT LABORATORIES (ABT) executive vice president and chief financial officer Philip P. Boudreau reported a Form 4 showing that on September 1, 2026, 388 common shares were disposed of at $110.36 per share to satisfy exercise price or tax liability obligations. After this withholding, he holds 70,784 common shares directly, plus indirect holdings of 9,332 shares in the Abbott Laboratories Stock Retirement (Profit Sharing) Trust and 2,200 shares held by his spouse. No Rule 10b5-1 trading plan is affirmed.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise Price or Tax Liability: 388 shares
Exercise Price or Tax Liability
3 txns
Insider
Boudreau Philip P
Role
EVP AND CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common shares without par value | 388 | $110.36 | $43K |
| holding | Common shares without par value F1 | -- | -- | -- |
| holding | Common shares without par value | -- | -- | -- |
Holdings After Transaction:
Common shares without par value — 70,784 shares (Direct);
Common shares without par value — 9,332 shares (Indirect, Profit Sharing Trust);
Common shares without par value — 2,200 shares (Indirect, By Spouse)
Footnotes (1)
- F1. Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2026.
Key Figures
Shares delivered/withheld for exercise price or tax liability: 388 shares
Price per share for code F disposition: $110.36 per share
Direct common shares after transaction: 70,784 shares
+2 more
5 metrics
Shares delivered/withheld for exercise price or tax liability
388 shares
Common shares disposed of on September 1, 2026 under transaction code F
Price per share for code F disposition
$110.36 per share
Value used for the 388-share exercise-price-or-tax-liability disposition
Direct common shares after transaction
70,784 shares
Direct holdings of Philip P. Boudreau following the September 1, 2026 event
Indirect shares in Profit Sharing Trust
9,332 shares
Balance in Abbott Laboratories Stock Retirement Trust as of September 1, 2026
Indirect shares held by spouse
2,200 shares
Indirect ownership reported as held by spouse after the transaction
Key Terms
Payment of exercise price or tax liability, Profit Sharing Trust, Common shares without par value
3 terms
Payment of exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
Profit Sharing Trust financial
"Indirect ownership nature described as Profit Sharing Trust"
FAQ
What transaction did ABT’s EVP and CFO Philip P. Boudreau report on this Form 4?
He reported that on September 1, 2026, 388 common shares of Abbott Laboratories were disposed of to provide payment of exercise price or tax liability by delivering or withholding securities, rather than as an open-market sale.
What indirect ownership in Abbott Laboratories (ABT) does Philip P. Boudreau report?
He reports indirect ownership of 9,332 shares held in a Profit Sharing Trust (the Abbott Laboratories Stock Retirement Trust, as of September 1, 2026) and 2,200 shares held by his spouse.
Was the ABT Form 4 transaction made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked, and no footnote indicates that the September 1, 2026 transaction was made under a Rule 10b5-1 trading plan.
Did Philip P. Boudreau report any derivative exercises of ABT securities in this filing?
No. The filing’s summary shows no derivative transactions and no exercises of options or other derivative securities; it reports only a code F disposition and updated share holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
